Share：
Share this content in WeChat
X
[Chinese][PDF]68469
• Highlights •
Current status of MR imaging for vulnerable plaque in clinical application
ZHANG Zhao-qi  DONG Li  YU Wei 

DOI:10.3969/j.issn.1674-8034.2010.06.006.


[Abstract] Atherosclerotic plaque rupture and thrombosis are considered to be induced cardiovascular event. Imaging plays an important role in the management of atherosclerosis, and cardiovascular magnetic resonance (CMR) of the carotid vessel wall is one promising modality in the evaluation of patients with carotid atherosclerotic disease. This review summarizes the current state of knowledge regarding carotid vessel wall CMR and its potential clinical application for management of carotid atherosclerotic disease.
[Keywords] Atherosclerosis；Carotid arteries；Vulnerable plaque；Magnetic resonance imaging

ZHANG Zhao-qi* Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

DONG Li Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

YU Wei Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

*Correspondence to: Zhang ZQ, E-mail: zhaoqi5000@vip.sohu.com

Conflicts of interest   None.

Received  2010-09-10
Accepted  2010-10-14
DOI: 10.3969/j.issn.1674-8034.2010.06.006
DOI:10.3969/j.issn.1674-8034.2010.06.006.

[1]
Lusis AJ. Atherosclerosis. Nature, 2000, 407(6801):233-241.
[2]
Libby P, Geng Y, Aikawa M, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol, 1996,7(5):330-335.
[3]
Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005,352(16):1685-1695.
[4]
Zhang S, Cai J, Luo Y, et al. Measurement of carotid wall volume and maximum area with contrast-enhanced 3D MR imaging: initial observations. Radiology, 2003,228(1):200-205.
[5]
Kang X, Polissar NL, Han C, et al. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn Reson Med, 2000,44(6):968-972.
[6]
Alizadeh Dehnavi R, Doornbos J, Tamsma JT, et al. Assessment of the carotid artery by MRI at 3T: a study on reproducibility. J Magn Reson Imaging, 2007,25(5):1035-1043.
[7]
Vidal A, Bureau Y, Wade T, et al. Scan-rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T. Phys Med Biol, 2008,53(23):6821-6835.
[8]
Underhill H, Kerwin W, Hatsukami T, et al. Automated measurement of mean wall thickness in the common carotid artery by MRI: a comparison to intima-media thickness by B-mode ultrasound. J Magn Reson Imaging, 2006,24(2):379-387.
[9]
Moreno PR, Lodder RA. Detection of lipid pool, thin fibrous cap and inflammatory cells in human aortic atherosclerotic plaque by near-infarct-enspectroscopy. Circulation, 2002,105(4):923-925.
[10]
Fabiano S, Mancino S, Stefanini M, et al. High-resolution multicontrast-weighted MR imaging from human carotid endarterectomy specimens to assess carotid plaque components. Eur Radiol, 2008,18(12):2912-2921.
[11]
Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol, 2005,25(1):234-239.
[12]
Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging, 2002,15(1):62-67.
[13]
Wasserman BA, Smith WI, Trout HH, et al. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology, 2002,223(2):566-573.
[14]
Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation, 2005, 112(22): 3437-3444.
[15]
Kockx M, Cromheeke K, Knaapen M, et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol, 2003,23(3):440-446.
[16]
Virmani R, Kolodgie F, Burke A, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol, 2005,25(10):2054-2061.
[17]
Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke, 2004,35(5):1079-1084.
[18]
Moody A, Murphy R, Morgan P, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation, 2003,107(24):3047-3052.
[19]
Stary H. Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol, 2000,89(Suppl 2):28-35.
[20]
Mintz G, Pichard A, Popma J, et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol, 1997,29(2):268-274.
[21]
Raggi P, Callister T, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation, 2000,101(8):850-855.
[22]
Taylor A, Burke A, O'Malley P, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation, 2000,101(11):1243-1248.
[23]
Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation, 2001,104(14):1682-1687.
[24]
Huang H, Virmani R, Younis H, et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation, 2001,103(8):1051-1056.
[25]
Cheng G, Loree H, Kamm R, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation, 1993,87(4):1179-1187.
[26]
Alderman E, Corley S, Fisher L, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol, 1993, 22(4): 1141-1154.
[27]
Li Z, Howarth S, Tang T, et al. Does calcium deposition play a role in the stability of atheroma? Location may be the key. Cerebrovasc Dis, 2007,24(5):452-459.
[28]
Li Z, U-King-Im J, Tang T, et al. Impact of calcification and intraluminal thrombus on the computed wall stresses of abdominal aortic aneurysm. J Vasc Surg, 2008,47(5):928-935.
[29]
Moreno P, Purushothaman K, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation, 2004,110(14):2032-2038.
[30]
Mofidi R, Crotty T, McCarthy P, et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg, 2001,88(7):945-950.
[31]
Kerwin W, O'Brien K, Ferguson M, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology, 2006,241(2):459-468.
[32]
Kerwin W, Oikawa M, Yuan C, et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med, 2008,59(3):507-514.
[33]
Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation, 2003,107(6):851-856.
[34]
Trivedi R, U-King-Im J, Graves M, et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke, 2004,35(7):1631-1635.
[35]
Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology, 2006,240(2):464-472.
[36]
Sadat U, Weerakkody R, Bowden D, et al. Utility of high resolution MR imaging to assess carotid plaque morphology: A comparison of acute symptomatic, recently symptomatic and asymptomatic patients with carotid artery disease. Atherosclerosis, 2009,207(2):434-439.
[37]
Howarth S, Tang T, Trivedi R, et al. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol, 2009,70(3):555-560.
[38]
Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke, 2006,37(3):818-823.
[39]
Altaf N, Daniels L, Morgan P, et al. Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg, 2008,47(2):337-342.
[40]
Saam T, Cai J, Cai Y, et al. Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol, 2005,25(3):611-616.
[41]
Saam T, Yuan C, Chu B, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis, 2007,194(2):e34-42.
[42]
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med1998;339(19):1349-1357.
[43]
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002,360(9326):7-22.
[44]
Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006,355(6):549-559.
[45]
Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation, 2002,106(23):2884-2887.
[46]
Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol, 2005,46(1):106-112.
[47]
Underhill HR, Yuan C, Zhao XQ, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J, 2008,155(3):584 e581-588.
[48]
Zhao XQ, Dong L, Hatsukami TS, et al. Magnetic resonance imaging of the plaque lipid depletion during lipid therapy: a prospective assessment of efficacy and time-course. DOI: , 2009.
[49]
Underhill HR, Yuan C, Yarnykh VL, et al. Arterial remodeling in the subclinical carotid artery: A natural history study. JACC Cardiovasc Imaging, 2009,2(12):1381-1389.
[50]
Dong L, Kerwin W, Chen HJ, et al. Effect of intensive lipid therapy on atherosclerotic plaque inflammation: evaluation using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in carotid disease. Radiology, DOI: .
[51]
Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol, 2009,53(22):2039-2050.
[52]
Underhill HR, Hatsukami TS, Cai J, et al. A noninvasive imaging approach to assess plaque severity: the carotid atherosclerosis score. AJNR Am J Neuroradiol, 2010,31(6):1068-1075.

PREV Advantage and disadvantage of MR imaging for vulnerable plaque
NEXT MR imaging of vulnerable plaque: consensus and challenges
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn